Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close.

نویسندگان

  • Steven R Messé
  • Scott E Kasner
چکیده

A quick PubMed search reveals an abundance of editorials, reviews, and opinion pieces on the subject of patent foramen ovale (PFO) management, and this is now the fourth published article on this topic that has adapted William Shakespeare’s classic words from Hamlet to describe the conundrum that faces neurologists, cardiologists, and their patients.1–3 The degree to which this title has been overused reflects the tremendous uncertainty that clinicians feel about patients who have had a stroke and are found to have a PFO. The reason for this confusion is that high-level, unbiased data do not yet exist to guide our clinical decisions with these challenging patients. The Food and Drug Administration rescinded the prior Humanitarian Device Exemption for percutaneous PFO closure devices to spur research into this clinical question.4 Unfortunately, although the National Inpatient Sample demonstrated a 50-fold increase in the number of percutaneous PFO/atrial septal defect closure procedures over a 6-year period ending in 2004, enrollment in clinical trials has continued to be slow, suggesting that many patients are receiving percutaneous PFO closure with the use of offlabel atrial septal defect devices.5 The rampant off-label closure of PFOs is both hindering the progress of randomized controlled trials and undermining their validity. So, to answer the titular question: do NOT close the PFO, EXCEPT in the setting of a randomized trial. Response by Windecker and Meier p 2004

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Percutaneous closure of a patent foramen ovale after cryptogenic stroke

A patent foramen ovale is a common intracardiac finding that is located between the left and right atrium. It can cause right-to-left shunting and has a high prevalence in patients who suffer a cryptogenic stroke. Earlier trials did not show superiority of percutaneous patent foramen ovale closure with standard medical therapy over standard medical therapy alone in the treatment of cryptogenic ...

متن کامل

Patent foramen ovale and cryptogenic stroke: the hole story.

Despite 3 recent randomized clinical trials, the management of patients with cryptogenic stroke and patent foramen ovale remains unsettled. The primary results of Evaluation of the STARFlex Septal Closure System in Patients with a Stroke and/or Transient Ischemic Attack due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale (CLOSURE), Percutaneous Closure of Patent Foramen Ovale in...

متن کامل

Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else!

A 39-year-old mother of 2 teenage boys complained of severe migraine with aura for 10 years. Otherwise healthy, she suffered an ischemic stroke that rendered her permanently aphasic. Diagnostic evaluation revealed no evidence of atherosclerosis of the carotid arteries or plaques of the ascending aorta and the aortic arch. The ECG showed normal sinus rhythm, and the patient denied any history of...

متن کامل

Management of patent foramen ovale in cryptogenic stroke.

There is currently no consensus on the optimal management of cryptogenic stroke in the presence of a patent foramen ovale (PFO). Some physicians do not believe in the added value of PFO closure in cryptogenic stroke, whereas, for others, cryptogenic stroke represents a situation where PFO closure would be the best management. Because of a lack of well-designed randomized trials, guidelines do n...

متن کامل

Ischemic Stroke in Patients with Percutaneous Patent Foramen Ovale Closure

Background: The prevalence of patent foramen ovale is approximately 50% in patients who have suffered a cryptogenic stroke. The recurrence of ischemic stroke after percutaneous patent foramen ovale closure is approximately 1% per year. Objective: The aim of this study was to evaluate the prevalence of recurrent ischemic stroke in our population undergoing percutaneous patent foramen ovale closu...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Circulation

دوره 118 19  شماره 

صفحات  -

تاریخ انتشار 2008